Okthobha 2026 — Udibaniso lwe-fecal calprotectin kunye novavanyo lwe- *Helicobacter pylori* lwe-antigen yestool luvela njengendlela esebenzayo yokuvavanya iimpawu zesisu, lunika oogqirha indlela elula yokuvavanya ukudumba kwamathumbu kunye nosulelo lweebhaktheriya kwisampuli enye yestool.

Uphando lwakutshanje luye lwaqinisa izizathu zonyango zovavanyo oludibeneyo. Uphononongo oluza kupapashwa ngo-2026 lufumanise ukuba amazinga e-calprotectin endle ayephezulu kakhulu kwizigulane ezine-*H. pylori* xa kuthelekiswa nolawulo olungalunganga, kwaye amanqanaba ehla kakhulu emva konyango oluphumeleleyo lokuphelisa. Olu phononongo lufanayo lubike ulwalamano olubalulekileyo phakathi kwamanqanaba e-calprotectin kunye nenqanaba le-histological le-gastritis ebangelwa yi-*H. pylori*, nto leyo ebonisa ukuba ezi mpawu zimbini zinokubonelela ngolwazi oluhambelanayo malunga nokudumba kwesisu namathumbu.

Ezi ziphumo zihambelana nobungqina obandayo obubonisa ukuba usulelo lwe-*H. pylori* lunokuchaphazela amazinga e-calprotectin. Uphononongo oluvela e-Iraq oluphanda olu lwalamano luphawule ukuba uphando lwangaphambili kubantwana nakubantu abadala luye lwabonisa rhoqo ukuba i-calprotectin iphezulu kubantu abosulelekileyo, kwaye iqhelekile emva kokupheliswa.

Ngokwembono yorhwebo, uvavanyo oludibeneyo luyanda. Kwi-ESGE Days 2026 eMilan, iSentinel Diagnostics igxininise indlela yayo edibeneyo yokuxilongwa kwe-GI, iveza uvavanyo oluzenzekelayo lwe-immunoturbidimetric lwe-calprotectin kunye ne-*H. pylori* njengenxalenye yephaneli edibeneyo yokuvavanya izigulane ezineempawu. Le nkampani igxininise ukuba le modeli edibeneyo ixhasa ukwahlulwahlulwa komngcipheko kunye nokudluliselwa kwe-endoscopic okufanelekileyo ngakumbi.

Okwangoku, i-ALPCO isandula ukwandisa imenyu yayo yovavanyo lwe-GI enelayisenisi ye-Health Canada ukuze ibandakanye i-*H. pylori* stool antigen kunye ne-calprotectin kwiqonga le-KleeYa® elizenzekelayo, ikhankanya imfuno yelabhoratri yezisombululo zovavanyo ezidibeneyo. Le nkampani ibike ukusebenza okungcono kakhulu kovavanyo lwayo lwe-calprotectin ekwahlukaniseni isifo samathumbu esivuthayo kwi-irritable bowel syndrome.

Nangona kunjalo, imingeni yeziseko zophuhliso isaqhubeka. E-United Kingdom, utshintsho lweenkonzo zelebhu ye-NHS lubangele ukulibaziseka kokuguquka, kunye nokusilela kwe-*H. pylori* antigen kunye ne-calprotectin okubikwe malunga neentsuku ezisi-7 kunye ne-12 ngokulandelelana ukusukela ngo-Okthobha ka-2026. Ilebhu iqinisekisile ukuba uzinzo lwesampulu aluchaphazeleki kwaye amatyala angxamisekileyo anokubekwa phambili.

Kwabo bagqirha, le ndlela idibeneyo inika impumelelo yokusebenza ngaphandle kokubeka emngciphekweni isivuno sokuxilonga. Njengoko iinkqubo zempilo zijongene noxinzelelo olukhulayo lokuphucula amandla e-endoscopy, uvavanyo oluhlanganisiweyo lwesitulo se-calprotectin kunye ne-*H. pylori* lumele inyathelo elisebenzayo lokufumana i-triage yezigulane efanelekileyo, esekelwe kubungqina.

Siyakwazi ukunika iinkonzo zonyango ze-baysenUvavanyo lwe-calprotectin kunye ne-H-Pylori Antigen comboWamkelekile ukuba unxibelelane nathi ukuba unesidingo.